Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/ salmeterol combination treatment in subjects with persistent asthma

Background Mometasone furoate/formoterol (MF/F) is a novel combination therapy for treatment of persistent asthma. This noninferiority trial compared the effects of MF/F and fluticasone propionate/salmeterol (FP/S) combination therapies on pulmonary function and onset of action in subjects with persistent asthma.